Scientists have found a way to lower stroke risk in sickle cell patients that opens a gateway of potential treatments for inflammation and clotting stemming from conditions such as COVID-19. For the first time, they investigated the use of immune cell proteins as an anti-inflammatory treatment to reduce blood clotting in people with sickle cell disease.